Lee W. Thompson

Terminal modifications inhibit proteolytic degradation of an immunogenic mart-127-35 peptide: Implications for peptide vaccines

Laurence H. Brinckerhoff, Lee W. Thompson, Galina V. Yamshchikov et al. · International Journal of Cancer · 1999 · 168 citations

Pharmacy, Immunology, Pharmacokinetics +17

Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development

David J. Kittlesen, Lee W. Thompson, Pamela H. Gulden et al. · The Journal of Immunology · 1998 · 135 citations · Full text

Life Sciences, Immunology, Oncology +17

Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens

Craig L. Slingluff, Teresa A. Colella, Lee W. Thompson et al. · Cancer Immunology Immunotherapy · 2000 · 96 citations · Full text

Medicine, Immunology, Oncology +17

Sequential Immune Escape and Shifting of T Cell Responses in a Long-Term Survivor of Melanoma

Galina V. Yamshchikov, David W. Mullins, Chien‐Chung Chang et al. · The Journal of Immunology · 2005 · 93 citations · Full text

Life Sciences, Immunology, Oncology +17

Deletion of the NMDA Receptor GluN2A Subunit Significantly Decreases Dendritic Growth in Maturing Dentate Granule Neurons

Timal S. Kannangara, Crystal A. Bostrom, Andrea Ratzlaff et al. · PLoS ONE · 2014 · 35 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17